Heterogeneity of breast cancer I stage: clinical and prognostic value of the carcinoma size T1A, T1B and T1C
- Authors: Kolyadina I.V.1,2, Poddubnaya I.V1,2, Trofimova O.P2, Frank G.A1, Komov D.V2, Karseladze A.I2, Ozhereliev A.S2
-
Affiliations:
- Russian Medical Academy of Postgraduate Education
- N.N. Blokhin Russian Cancer Research Center
- Issue: Vol 20, No 1 (2015)
- Pages: 17-22
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40107
- DOI: https://doi.org/10.17816/onco40107
- ID: 40107
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Irina V. Kolyadina
Russian Medical Academy of Postgraduate Education; N.N. Blokhin Russian Cancer Research Center
Email: irinakolyadina@yandex.ru
MD, PhD 123995, Moscow, Russian Federation
I. V Poddubnaya
Russian Medical Academy of Postgraduate Education; N.N. Blokhin Russian Cancer Research Center123995, Moscow, Russian Federation
O. P Trofimova
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian
G. A Frank
Russian Medical Academy of Postgraduate Education123995, Moscow, Russian Federation
D. V Komov
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian
A. I Karseladze
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian
A. S Ozhereliev
N.N. Blokhin Russian Cancer Research Center115478, Moscow, Russian
References
- GLOBOGAN 2012; www.http://globocan.iarc.fr
- Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2013 году. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2014. www.
- Аксель Е.М. Заболеваемость и смертность от рака молочной железы в России. В кн.: Материалы большой конференции RUSSCO «Рак молочной железы» 22-24 января 2014 г. М.; 2014: 35-8.
- Livi L., Meattini I., Saieva C. et al. Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. Cancer2012; 118 (13): 3236-43.
- Gonzalez-Angulo A.M., Litton J.K., Broglio K.R. et al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J. Clin. Oncol. 2009; 27 (34): 5700-6.
- Schroeder M.C., Lynch C.F., Abu-Hejleh T. et al. Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010-2012. Clin. Breast Cancer. 2014 Aug 18. pii: S1526-8209(14)00164-5.
- Harbeck N., Thomssen Ch., Gnant M. Brief Preliminary Summary of the Consensus Discussion. Breast Care (Basel). 2013; 8 (2): 102-9.
- NCCN breast cancer guidelines professionals http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#breast
- Schroeder M.C., Lynch C.F., Abu-Hejleh T., Chrischilles E. A., Thomas A. Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010-2012. Clin. Breast Cancer. 2014; 18. pii: S1526-8209 (14): 164-5.
- Langagergaard V, Garne J.P., Vejborg I., Schwartz W., Bak M., Lernevall A. et al. Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography Screening. Clin Epidemiol. 2013; 5: 81-8.